Pfizer, Apotex End Patent Fight Over Generic Lipitor
An Illinois federal judge on Thursday dismissed Pfizer Inc.'s patent infringement suit against Canadian drugmaker Apotex Inc. over a generic version of anti-cholesterol drug Lipitor after the parties announced they had...To view the full article, register now.
Already a subscriber? Click here to view full article